Galactose mutarotase deficiency is a rare inherited condition that affects how the body handles galactose, a sugar found in milk. It is usually recognized in newborns or young infants, and early signs of Galactose mutarotase deficiency can include cataracts, feeding problems, or high galactose levels on newborn screening. Not everyone will have the same experience. Galactose mutarotase deficiency is lifelong, but treatment often includes a low-galactose diet, close follow-up, and eye care if cataracts develop. Deaths from Galactose mutarotase deficiency are not commonly reported, though infants still need prompt medical care and monitoring.
How many people live with Galactose mutarotase deficiency?
Reliable worldwide and U.S. counts for galactose mutarotase deficiency have not been published. MedlinePlus Genetics describes it as extremely rare, with only a few reported cases worldwide (MedlinePlus Genetics, 2024), and a separate estimate for how many people live with it in the United States is not available (MedlinePlus Genetics, 2024).
Overview
Galactose mutarotase deficiencySymptoms
Galactose mutarotase deficiency can cause trouble processing milk sugar. Signs may include vomiting, poor feeding, jaundice, low blood sugar, or poor growth in infancy. Some people have milder features and are found only on newborn screening.
Outlook and prognosis
With Galactose mutarotase deficiency, outlook often depends on how strongly the body reacts to galactose and how early it is recognized. Many living with Galactose mutarotase deficiency do well with careful follow-up, while some may need ongoing monitoring for feeding, growth, or cataracts.
Causes and risk factors
Galactose mutarotase deficiency is caused by changes in the GALM gene, usually inherited from both parents. Risk is highest if each parent carries the changed gene; symptoms can be shaped by how much galactose is in the diet.
Genetic influences
Genetics are central to galactose mutarotase deficiency, because it is caused by disease-causing changes in the GALM gene. Different genetic variations can affect how much enzyme activity remains, so symptoms and the age they start may vary.
Diagnosis
Galactose mutarotase deficiency is usually suspected from clinical features and routine blood tests. The diagnosis of galactose mutarotase deficiency is confirmed with genetic tests, often alongside urine or blood findings showing problems handling galactose.
Treatment and drugs
Treatment for galactose mutarotase deficiency usually centers on a low-galactose diet, often by limiting milk and other dairy foods. Many living with galactose mutarotase deficiency also need regular follow-up to track growth, nutrition, and any symptoms.
Symptoms
Parents may first notice that a baby's eye looks cloudy or that a child is not seeing clearly as expected. In Galactose mutarotase deficiency, the main signs usually involve the eyes, especially cataracts, though some children have very few outward problems. Some are first picked up on newborn screening because blood tests show high galactose, and the changes are often subtle at first.
One of the early features of Galactose mutarotase deficiency is cataracts, which means the normally clear lens of the eye becomes cloudy. This may give the pupil a white, gray, or dull look. In babies, parents may notice less steady eye contact or poor tracking of faces and toys.
If cataracts affect how light passes through the eye, vision can be blurry or dim. Some children may squint, seem bothered by bright light, or miss small objects in front of them. How much this affects daily life depends on how dense the cataracts are and whether one or both eyes are involved.
Many people with Galactose mutarotase deficiency are found because newborn screening or blood tests show high galactose, a sugar from milk. This lab change may happen even when a baby seems well. It is a sign doctors look for rather than something a child can feel.
Some babies and children with this condition do not seem ill in day-to-day life outside of the eye findings. They may feed, grow, and act as expected, especially when the cataracts are mild. Because Galactose mutarotase deficiency is rare, doctors often use eye exams and lab tests to see how much it is affecting a child.
How people usually first notice Galactose mutarotase deficiency?
Galactose mutarotase deficiency is usually first noticed in infancy, often soon after milk feeding begins, because the body has trouble handling galactose, a sugar found in breast milk and formula. The first signs of galactose mutarotase deficiency can include poor feeding, vomiting, jaundice, unusual sleepiness, low blood sugar, or trouble gaining weight, although some babies have milder signs and are picked up only through newborn screening. In many families, how galactose mutarotase deficiency is first noticed is either an abnormal newborn blood test or a baby who seems to get sick after feeds, which is why quick medical evaluation matters.
Types of Galactose mutarotase deficiency
No distinct types of Galactose mutarotase deficiency are widely recognized.
Can I slow down the onset of symptoms?
Probably only partly: for galactose mutarotase deficiency, a rare inherited problem with handling part of milk sugar, there is no good evidence that general lifestyle steps like exercise, sleep, or supplements can meaningfully delay symptoms, but starting a low-galactose or low-lactose diet early may help reduce the chance of problems such as cataracts in some people. Because this condition is very rare, the research is still limited, so this may lower risk rather than prevent the condition, and it cannot promise that symptoms will never appear. Early diagnosis and close follow-up can still be helpful, and while the outlook varies from person to person, acting early gives the best chance of limiting problems.
What genetics can tell you about symptoms
Genetics can give some clues about symptoms in galactose mutarotase deficiency, but not a precise forecast. Different changes in the GALM gene may leave more or less enzyme activity, which can affect whether someone has few or no symptoms or develops problems such as cataracts early in life, sometimes even in the newborn period. Because this condition is very rare and symptoms can vary widely even among people with the same condition, genetic results usually help confirm the diagnosis more than they predict exactly how severe symptoms will be or when they will begin.
Causes and risk factors
Trouble often shows up after milk feeds, because people with galactose mutarotase deficiency cannot process galactose, a sugar that comes from lactose, in the usual way. The underlying cause is a change in the GALM gene, and a child usually inherits one changed copy from each parent. The main risk factors for galactose mutarotase deficiency are a family history, parents who both carry the gene change, and parents who are closely related. Having a gene change does not always mean symptoms will be severe. Milk or lactose in early feeding can affect when the condition is noticed, but it does not cause the gene change.
What are the most common causes or risk factors?
Galactose mutarotase deficiency is almost always caused by inheriting two changed copies of the GALM gene, one from each parent. The main risk factors are a family history of the condition and having parents who both carry one changed copy of this gene, even if they are healthy themselves; the chance can also be higher when the parents are related by blood. Milk feeding with breast milk or standard formula does not cause the disorder, but the galactose in milk can bring it to light in a baby who was born with it.
Environmental and biological risk factors
When people look up risk factors for galactose mutarotase deficiency, it helps to know that current evidence is limited because the condition is very rare. Awareness of both biological and environmental influences helps you feel prepared. So far, no outside exposure, routine pregnancy issue, or birth event has been clearly shown to cause it, and the main known drivers are body-based factors present from conception.
Galactose mutarotase deficiency is usually tied to a body-based change that is already present from conception. This means the chance is generally set very early, rather than being created by something later in pregnancy or after birth.
No environmental exposure has been clearly shown to cause galactose mutarotase deficiency. This includes common concerns such as air pollution, household chemicals, or everyday infections.
Common maternal health problems, such as diabetes, high blood pressure, or thyroid disease, are not known causes of galactose mutarotase deficiency. They can matter for pregnancy care, but they have not been shown to create this condition.
Older maternal or paternal age is not a recognized risk factor for galactose mutarotase deficiency. That differs from some chromosome conditions, where age can change the chance of a baby being affected.
Genetic risk factors
Galactose mutarotase deficiency usually stems from changes in a single gene called GALM. For families looking into the genetic causes of galactose mutarotase deficiency, the answer usually centers on this gene and the way it is inherited. Carrying a genetic change doesn’t guarantee the condition will appear, because most carriers have one changed copy and stay healthy.
GALM gene: Galactose mutarotase deficiency is caused by harmful changes in the GALM gene. This gene helps the body process galactose, a sugar found in milk and some other foods.
Two changed copies: The condition usually appears only when both copies of the GALM gene are not working properly. This inheritance pattern is called autosomal recessive.
Carrier parents: When both biological parents carry one changed GALM copy, each pregnancy has a 25% chance of the child having galactose mutarotase deficiency. There is also a 50% chance the child will be a carrier and a 25% chance the child will inherit two working copies.
Family history: A family history of galactose mutarotase deficiency can raise the chance that other relatives also carry the same gene change. This is especially important if a sibling or close relative has been diagnosed.
Related parents: If the biological parents are related by blood, they are more likely to carry the same rare GALM change. That can increase the chance of recessive conditions like galactose mutarotase deficiency in their children.
Lifestyle risk factors
Galactose mutarotase deficiency is an inherited disorder of galactose metabolism, so lifestyle habits do not cause it. However, how lifestyle affects Galactose mutarotase deficiency is still important because everyday feeding patterns can influence galactose exposure, symptom control, and complication risk. The main practical issue is limiting excess galactose, especially in infancy and early childhood, when cataracts have been reported most often.
Regular intake of lactose-rich milk, standard infant formula, and other dairy foods increases the galactose load that the body must process. In Galactose mutarotase deficiency, this can raise galactose-related metabolites and may increase the chance of problems such as cataracts.
Processed foods, supplements, and medications can sometimes contain lactose or galactose-containing ingredients without being obvious. Repeated small exposures may make dietary control harder and can matter in people who are being treated with galactose restriction.
Early feeding choices are especially important because newborns and infants often consume milk as their main calorie source. If symptoms or cataracts appear, using an appropriate low-galactose feeding plan under metabolic guidance may reduce ongoing galactose stress.
Inconsistent restriction of galactose can lead to fluctuating exposure from day to day. More stable eating habits make it easier for the care team to judge whether diet is helping and whether symptoms are improving.
Risk prevention
For people living with galactose mutarotase deficiency, true prevention of the genetic condition itself is not usually possible. Prevention mainly means lowering the chance of symptoms and long-term complications by limiting galactose exposure, checking nutrition, and following up with a metabolic specialist. This often matters most in infancy, when milk feeding can quickly lead to problems, but prevention remains important later in life as well. Prevention is flexible—it adapts to your life and health background.
The main way to reduce risk in galactose mutarotase deficiency is to avoid or limit foods that contain galactose, especially regular milk and dairy. This can help prevent feeding problems, poor growth, liver stress, and other early symptoms of galactose mutarotase deficiency.
Newborns with galactose mutarotase deficiency may need a non-milk formula chosen with their medical team. Starting the right feed early can lower the risk of serious illness in the first days or weeks of life.
Some processed foods, supplements, and medicines may contain lactose or galactose-related ingredients. Reading labels and asking a pharmacist when needed can help avoid hidden exposures.
Regular visits with a metabolic doctor or dietitian help make sure the diet is safe, practical, and still meeting nutritional needs. Prevention works best when combined with regular check-ups.
Can you prevent Galactose mutarotase deficiency?
No, galactose mutarotase deficiency itself usually cannot be prevented, because it is an inherited condition that a baby is born with. If it runs in your family, genetic counseling and carrier testing before or during pregnancy may help you understand the chance of having a child with it, but they cannot guarantee prevention. Early newborn screening and starting the right diet quickly can often help prevent serious health problems, even though they do not prevent the condition itself.
Transmission
Galactose mutarotase deficiency is not infectious, so it cannot be passed from one person to another through coughing, kissing, sex, food, or everyday contact. Instead, the genetic transmission of Galactose mutarotase deficiency happens when a child inherits two nonworking copies of the related gene, usually one from each parent.
Many living with Galactose mutarotase deficiency were born to parents who are healthy carriers and do not know they carry the change. If both parents are carriers, each pregnancy has a 1 in 4 chance that the baby will have the condition, which is why understanding how Galactose mutarotase deficiency is inherited can be helpful for family planning and genetic counseling.
When to test your genes
Genetic testing is most useful if a newborn or child has unexplained jaundice, liver problems, cataracts, poor feeding, or a family history of galactosemia. It can confirm GALM deficiency early, guide a galactose-restricted diet, and help with family planning.
Diagnosis
Galactose mutarotase deficiency is often first suspected after a newborn screen shows high galactose levels, or when a baby develops feeding problems or early cataracts. Some babies seem well at first, while others may have signs that prompt a closer look in the first weeks of life. Getting a diagnosis is often a turning point toward answers and support. Because this condition is rare, the diagnosis of Galactose mutarotase deficiency usually combines lab results, clinical features, and genetic confirmation.
Galactose mutarotase deficiency may first come to attention when routine newborn screening finds elevated galactose or related markers in the blood. This result does not confirm the condition by itself, but it tells doctors that more testing is needed.
Doctors ask about feeding, vomiting, poor weight gain, sleepiness, and whether cataracts have been noticed early in life. A careful review of symptoms helps show whether the lab findings fit Galactose mutarotase deficiency or another form of galactosemia.
Blood and urine tests look for abnormal handling of galactose and help rule out more common causes of similar symptoms. Tests may feel repetitive, but each one helps rule out different causes.
An eye specialist may check for cataracts, which can be an important clue in some babies with Galactose mutarotase deficiency. Finding cataracts does not prove the diagnosis, but it can strongly support it when paired with lab results.
How is Galactose mutarotase deficiency diagnosed?
Galactose mutarotase deficiency is usually suspected when newborn screening or follow-up blood and urine tests show that a baby is not handling galactose, a sugar in milk, in the usual way. Doctors also look at the overall picture, including signs such as feeding problems, vomiting, poor weight gain, or early cataracts, and they use lab tests to rule out the more common forms of galactosemia. Genetic testing can then help confirm the diagnosis by finding changes in the GALM gene.
Stages of Galactose mutarotase deficiency
Galactose mutarotase deficiency does not have defined progression stages. This is because it is usually identified by how the body handles galactose, a sugar found in milk, rather than by a steady pattern of worsening over time. Doctors usually start with a conversation about feeding, growth, and any early symptoms of Galactose mutarotase deficiency, such as problems after milk feeds or cataracts in infancy. Diagnosis is usually confirmed with blood or urine tests and, in some cases, genetic testing, while follow-up focuses on symptoms, diet, and eye checks if needed.
Outlook and prognosis
The outlook for galactose mutarotase deficiency appears to be generally favorable, especially when it is recognized early and managed with dietary reduction of galactose when needed. Reported individuals have often had a milder course than in classic galactosemia, with cataracts being a prominent complication in infancy or early childhood and the main risk if treatment is delayed. When cataracts are identified promptly, they may improve with dietary treatment in some patients, although others may still need ophthalmologic procedures. Because so few cases have been described, the long-term prognosis is still uncertain, and careful follow-up is recommended to watch for vision problems and any other unexpected complications. At present, there is no clear evidence that galactose mutarotase deficiency is associated with the high risk of life-threatening neonatal illness seen in classic galactosemia. Mortality data are not well established, but reported cases to date suggest survival is usually good with appropriate medical care.
Long-term effects
Galactose mutarotase deficiency can look very different from one person to another. Some people are found on newborn screening and stay generally well, while others develop early cataracts or later developmental concerns. Long-term effects vary widely, and the long-term effects of galactose mutarotase deficiency are still being mapped because the condition is so rare. Reports so far suggest vision and neurodevelopment are the main areas doctors watch over time.
Clouding of the eye lens can develop in infancy or early childhood and may become the clearest long-term feature. For some people, cataracts are the main lasting issue, while others with galactose mutarotase deficiency never develop them.
When cataracts occur, long-term vision may range from normal to reduced clarity depending on how much the lens and visual development were affected. Some may have ongoing eye findings that need follow-up over time.
A small number of reported children have had delays in speech, learning, or motor milestones. Others develop typically, so developmental effects are possible but not universal in galactose mutarotase deficiency.
Lab tests may continue to show signs that the body handles galactose differently, even when someone seems well day to day. At this stage, it is not fully clear how often these findings lead to later health problems.
How is it to live with Galactose mutarotase deficiency?
Living with galactose mutarotase deficiency can look very different from one person to another: some people stay well, while others, especially in infancy, may develop feeding problems or cataracts if galactose builds up in the body. For many living with this condition, daily life may include a galactose-restricted diet, regular follow-up with metabolic specialists, and eye checks, which can mean extra planning around milk, formula, and other dairy-containing foods. This can affect the whole household, because caregivers often need to read labels carefully, coordinate medical visits, and stay alert for symptoms, but with early diagnosis and ongoing care, many families are able to build a steady routine and help prevent complications.
Treatment and drugs
Galactose mutarotase deficiency is usually treated by lowering the amount of galactose in the diet, most often by avoiding lactose, the sugar found in milk and dairy foods. In babies, this often means switching to a lactose-free formula early, which can help reduce the risk of problems such as feeding trouble or cataracts. Treatment often looks different for each person, because some people with Galactose mutarotase deficiency have very mild symptoms while others need closer follow-up. Doctors may also monitor blood tests, growth, vision, and development over time, and if cataracts do not improve, eye treatment or surgery may be needed. Because this condition is rare, care is often guided by a metabolic specialist who can adjust the plan as your child grows.
Can you cure Galactose mutarotase deficiency?
No, there is no cure yet for galactose mutarotase deficiency, a rare inherited condition that makes it hard for the body to handle galactose, a sugar found in milk and some foods. For many living with it, treatment focuses on limiting galactose in the diet and having regular checkups to help prevent or manage problems such as cloudy lenses in the eyes. How much treatment is needed can vary from person to person.
Non-drug treatment
For many living with galactose mutarotase deficiency, care often centers on food choices and regular follow-up rather than medicines. In babies, treatment may start when feeding problems, jaundice, or cataracts raise concern, and early symptoms of galactose mutarotase deficiency can improve once galactose intake is reduced. Not every approach works the same way, because some people seem to have milder disease than others. Care is usually guided by a metabolic specialist and adjusted over time.
The main non-drug treatment is limiting galactose, usually by avoiding lactose-containing milk and dairy foods. For infants, this often means using a lactose-free or soy-based formula instead of standard formula or breast milk if advised by the care team. The exact level of restriction can vary with age and how severe the condition is.
A metabolic dietitian can help families build a safe eating plan that still supports growth, bone health, and everyday nutrition. This can make shopping, daycare meals, and school routines feel more manageable. As children get older, the plan may be adjusted based on symptoms and lab results.
Cataracts can be one of the earliest problems in galactose mutarotase deficiency, sometimes showing up in infancy. Regular eye exams help track whether cloudy lenses are improving with treatment or need further care. Quick follow-up matters if a baby is not making eye contact or seems sensitive to light.
Regular checks of weight, length or height, and developmental progress help the team spot feeding or learning concerns early. Some children may benefit from supportive therapies such as feeding therapy, speech therapy, or early intervention services if delays appear. Simple routines—like regular meals or follow-up visits—can have lasting benefits.
Your genes may have an impact on how drugs work for you
For people living with galactose mutarotase deficiency, treatment usually centers on food changes rather than a regular medicine, so there is no well-known genetic effect on how a standard drug for this condition works. In other words, this condition is not one where drug response testing is commonly used as part of care. If someone with this condition needs medicines for other health problems, their response can still vary for the usual reasons, and their care team will choose and adjust treatment based on symptoms, lab results, and overall health.
Pharmacological treatments
For galactose mutarotase deficiency, there is currently no specific medicine that corrects the underlying enzyme problem. Treatment usually focuses on limiting galactose in the diet, especially from lactose-containing foods, rather than relying on drugs. In some situations, medicines or supplements may be used to support nutrition or treat complications, but this depends on symptoms, age, and lab results.
There is no approved medication for galactose mutarotase deficiency itself at this time. For many living with galactose mutarotase deficiency, care is centered on diet and regular follow-up rather than a daily prescription.
Calcium and vitamin D supplements may be recommended if dairy intake is reduced for long periods. This can help support bone health, especially in children and teens who need steady growth.
If a newborn with early symptoms of galactose mutarotase deficiency becomes sick, dehydrated, or has low blood sugar, hospital treatment may include intravenous dextrose and fluids. These treatments do not fix the condition, but they can stabilize the body during an acute illness.
Genetic influences
Galactose mutarotase deficiency often first becomes a family concern when a newborn has trouble handling galactose, a sugar found in milk. This condition is caused by changes in the GALM gene, which helps the body process that sugar. People with galactose mutarotase deficiency inherit two changed copies of GALM, one from each parent, so it follows an autosomal recessive inheritance pattern. A carrier means someone has one changed copy of the gene and usually does not have symptoms. When both parents are carriers, each pregnancy has a 25% chance of galactose mutarotase deficiency, a 50% chance of having a carrier child, and a 25% chance of having a child without the gene change. Because carriers are often healthy, the genetic cause of galactose mutarotase deficiency may not be obvious until one child is diagnosed, and genetic testing can help clarify risks for siblings and future pregnancies.
Is Galactose mutarotase deficiency genetic?
Genetics are central to galactose mutarotase deficiency, because it is caused by disease-causing changes in the GALM gene. Different genetic variations can affect how much enzyme activity remains, so symptoms and the age they start may vary.
Having a genetic risk is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal part of human biology. Most do not directly affect health and are simply part of the natural differences among people. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many families, treatment of Galactose mutarotase deficiency centers more on food than on medicine, because the body has trouble handling galactose, a sugar found in milk and some other foods. Changes in the GALM gene can affect how strongly this shows up, so one baby may come to attention after cataracts or an abnormal newborn screening test, while another may have milder findings. Genetics is only one factor, but in Galactose mutarotase deficiency it helps doctors decide how closely to monitor the eyes, growth, and lab results and how strict a low-galactose or low-lactose diet may need to be. Unlike some inherited conditions, there is no well-established gene-targeted drug for Galactose mutarotase deficiency at this time, so treatment options for Galactose mutarotase deficiency mainly focus on diet and treating complications if they arise. The main value of genetic testing for Galactose mutarotase deficiency is to confirm the diagnosis, guide family screening, and avoid unnecessary treatments, rather than to choose a special medication dose.
Interactions with other conditions
For many living with Galactose mutarotase deficiency, the main issue is not a strong link with other diseases, but that its symptoms can look like other causes of feeding problems, jaundice, or early cataracts, especially in babies. This means doctors may need to rule out other forms of galactosemia and more common newborn illnesses before they can tell what is causing the problem. If someone with Galactose mutarotase deficiency also has another condition that affects the liver, eyes, or growth, it may be harder to sort out which condition is driving the symptoms at a given time. Interactions can look very different from person to person. At this point, there is no well-established evidence that Galactose mutarotase deficiency regularly causes a specific pattern of other diseases, but careful follow-up matters because the early symptoms of Galactose mutarotase deficiency can overlap with several childhood conditions.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Galactose mutarotase deficiency?
Symptoms can look a lot like other inherited problems that make it hard for the body to handle the milk sugar galactose, especially classic galactosemia and other rare forms of galactosemia. In babies, doctors may also need to rule out more common causes of poor feeding, vomiting, jaundice, or cloudy lenses in the eyes, such as infections or other liver problems.
History
Galactose mutarotase deficiency entered medicine more recently than many better-known inherited metabolic conditions, largely because its signs can overlap with other causes of feeding trouble, jaundice, or changes in blood sugar in early life. That made it easy to miss, especially when testing was limited and doctors grouped several galactose-related conditions together rather than separating them clearly.
As medical science evolved, better newborn screening and lab methods helped doctors see that Galactose mutarotase deficiency was a distinct condition, not simply a variation of another form of galactosemia. Researchers gradually recognized that some babies had abnormal handling of galactose, a sugar found in milk, even when the more familiar galactose disorders had been ruled out. This clearer picture mattered in everyday life: families who had once faced confusing results could begin to get a more specific explanation for why a newborn became sick after feeds or why test results did not fit the usual pattern.
In more recent years, researchers identified a genetic cause for Galactose mutarotase deficiency, which confirmed that it is its own disorder within the broader group of galactose metabolism conditions. Even so, the history of Galactose mutarotase deficiency is still developing compared with older diagnoses, and many living with the condition may find that published information is fairly limited. That does not mean the condition is poorly understood in the basics; rather, it reflects how rare it is and how recently it was separated from related disorders.
Today, the history of Galactose mutarotase deficiency helps explain why diagnosis can still take time and why the early symptoms of Galactose mutarotase deficiency may first look like other newborn illnesses. Looking back also shows how much progress has come from improved screening, more accurate biochemical testing, and closer follow-up of affected families.